Results 131 to 140 of about 118,660 (267)

Real‐World Treatment of Patients With Sinus Node Dysfunction and Heart Failure With Preserved Ejection Fraction

open access: yesPacing and Clinical Electrophysiology, EarlyView.
ABSTRACT Background Permanent pacemaker (PPM) implantation is recommended in patients with sinus node dysfunction (SND). In patients with coexisting heart failure with preserved ejection fraction (HFpEF), clinicians may be hesitant to treat SND due to concerns about exacerbating heart failure.
Nicole Habel   +4 more
wiley   +1 more source

Left Internal Mammary Artery Injury After Pacemaker Lead Implant—Case Report and Review of Literature

open access: yesPacing and Clinical Electrophysiology, EarlyView.
ABSTRACT We hereby report a case of a 75‐year‐old patient who developed a large left‐sided hemopneumothorax after a routine dual‐chamber pacemaker insertion. The rare complication was caused by the pacing lead injuring the left internal mammary artery (LIMA) after perforating the right ventricle.
Stuart Stenton   +3 more
wiley   +1 more source

Implementability of Point‐of‐Care Ultrasound for Paediatric Tuberculosis Diagnosis in Resource‐Constrained Settings: Experiences and Perspectives From Uganda

open access: yesTropical Medicine &International Health, EarlyView.
ABSTRACT Introduction Childhood tuberculosis (TB) remains a significant global health challenge, with a substantial number of cases going undiagnosed, particularly among children under five. Early diagnosis and intervention are crucial to reduce TB‐associated morbidity and mortality.
Julia van den Brink   +8 more
wiley   +1 more source

Extranodal marginal zone lymphoma presenting as a paraspinal mass and pleural effusion. [PDF]

open access: yesRespir Med Case Rep
Cami B   +5 more
europepmc   +1 more source

Identification of Novel Therapeutic Agent Candidates Through High Throughput Screening With Chemical Library Based on Molecular Subclassification in Canine Histiocytic Sarcoma Cell Lines

open access: yesVeterinary and Comparative Oncology, EarlyView.
ABSTRACT Effective chemotherapy for canine histiocytic sarcoma (CHS) has yet to be established. In our previous study, CHS cell lines were subclassified into two groups based on their gene expression profiles: Group A and Group B. This study aimed to identify novel therapeutic agents that are effective against each CHS subgroup, and we performed high ...
Hiroki Sakuma   +6 more
wiley   +1 more source

Immunodynamic changes in a mouse model of malignant pleural effusion. [PDF]

open access: yesLab Anim Res
Wei XL   +7 more
europepmc   +1 more source

Safety and Feasibility of Infusing Ex Vivo Expanded Allogeneic Canine Natural Killer Cells for the Treatment of Metastatic Solid Tumours

open access: yesVeterinary and Comparative Oncology, EarlyView.
ABSTRACT Companion canines need advances in therapeutic options for solid tumour malignancies. Natural killer (NK) cell infusions offer a promising treatment modality in canines with solid tumours. Autologous natural killer products are limited by dysfunctional immunity and a manufacturing process that delays care whereas allogeneic NK cells offer the ...
Allison M. Weisnicht   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy